University of Auckland Leads Pioneering Research into Psilocybin Mushroom Use

The University of Auckland is at the forefront of investigating the growing interest in psilocybin mushrooms, commonly known as magic mushrooms, in New Zealand. Through an innovative study titled "Psilocybin Mushroom Variability and Consumer Safety," researchers are delving into how these fungi are foraged, used, and their potential risks and benefits. Led by PhD candidate Samuel Lasham in the School of Pharmacy, the project highlights the university's commitment to harm reduction and public health research in higher education.

Psilocybin, the primary psychoactive compound in these mushrooms, has garnered attention for its potential therapeutic effects on mental health conditions. This research emerges amid reports of rising trends in foraging and self-medication practices across Aotearoa, positioning the University of Auckland as a key player in addressing these developments through evidence-based science.

Understanding Psilocybin Mushrooms: Biology and Cultural Context

Psilocybin mushrooms (Psilocybe species) contain psilocybin, which the body converts to psilocin, producing hallucinogenic effects. In New Zealand, common species like Psilocybe subaeruginosa grow in native beech forests and wood chip beds, making them accessible via foraging. Historically, indigenous Māori communities have explored psychoactive plants, and recent efforts are reclaiming these practices for addiction and mental health treatment.

The legal status classifies psilocybin as a Class A drug under the Misuse of Drugs Act 1975, yet drug checking services were enabled by 2022 regulations, allowing confidential testing. This framework supports university-led initiatives like the Auckland study, bridging research with community needs.

The Research Team and Their Expertise

Principal Investigator Dr. Rhys Ponton, a senior lecturer in the School of Pharmacy, holds New Zealand's only research drug-checking license. His group pioneered testing protocols for psychedelics. PhD student Sam Lasham, who founded Students for Sensible Drug Policy Aotearoa, specializes in mushroom genetics using DNA barcoding and environmental DNA from soil samples. Collaborators include Dr. Chris Pook from the Liggins Institute and Dr. Peter Buchanan from Manaaki Whenua Landcare Research, bringing interdisciplinary expertise in pharmacology, mycology, and ecology.

This team exemplifies how higher education institutions foster collaborative research, training the next generation of pharmacists and scientists equipped for emerging public health challenges. Opportunities abound in research jobs at universities like Auckland.

Study Methodology: From Interviews to Advanced Testing

The two-stage study began with in-person interviews (now complete) exploring acquisition, storage, preparation, and effects of psilocybin mushrooms. Stage two involves online surveys and voluntary sample submissions for free, confidential testing at the Grafton Campus Clinical Research Centre.

• Species identification via DNA barcoding to distinguish safe psilocybin varieties from toxic look-alikes like Galerina marginata.
• Potency analysis for psilocybin/psilocin content, a novel feature for harm reduction.
• Biochemical profiling to assess variability influencing user experiences.
• Interviews guided by lived-experience researchers for authentic insights.

Funded by the Health Research Council ($30,000), University of Auckland, and Ember Wellbeing Trust, the project adheres to strict ethics (AH27703). Such rigorous methods underscore the value of university research in drug policy.

Rising Foraging Trends and Community Practices

New Zealanders are increasingly foraging Psilocybe subaeruginosa in autumn woodlands, sharing tips via online forums and apps. Reports highlight underground retreats and microdosing for anxiety, depression, and even meth addiction recovery. Lasham's study reveals diverse preparation methods, from drying to tea infusions, amid growing self-treatment trends.

Challenges include seasonal availability and urban expansion encroaching on habitats. University research educates on safe foraging, reducing accidental poisonings—a critical public health role for higher ed institutions.

Safety Concerns: Toxicity Risks and Variability

While psilocybin is relatively low-risk, dangers lurk in misidentification. Galerina species mimic Psilocybe but contain deadly amatoxins, causing liver failure. 'Wood-lovers paralysis' from certain strains adds neurological risks. Potency varies by species, substrate, and storage, leading to unpredictable doses.

The study aims to develop clinic-ready protocols, empowering drug checking services nationwide.

Therapeutic Potential: Mental Health and Addiction

Emerging evidence supports psilocybin for treatment-resistant depression, with NZ's first psychiatrist approvals in 2025. University trials, including Māori-led ones with native strains, target addiction. Lasham's work documents self-reported benefits, informing clinical integration.

Higher education drives this shift, training therapists and pharmacists. Explore research assistant careers in psychedelics.

Cultural Reclamation and Māori Perspectives

Māori initiatives like Rangiwaho Marae's trials revive ancestral practices using indigenous Psilocybe species. Collaborations with universities blend tikanga with science, ensuring culturally safe research.

The University of Auckland's inclusive approach, involving lived-experience advisors, sets a model for equitable higher ed research.

Legal Framework and Harm Reduction Innovations

2022 drug checking regs enable legal sample testing without prosecution. UoA's licensed service tests for contaminants and potency, pioneering 'know your mushrooms' for festivals and clinics.

This positions NZ universities as leaders in policy-responsive research, influencing global standards.

Implications for New Zealand Higher Education

The study bolsters pharmacy curricula with real-world applications in mycology, analytics, and ethics. Student involvement like Lasham's fosters advocacy, preparing graduates for research assistant jobs in emerging fields.

Universities must navigate controversies, balancing innovation with safety. Rate professors like Dr. Ponton on Rate My Professor.

Future Outlook: Scaling Research and Services

Ongoing recruitment promises robust data for guidelines. Potential expansions include clinical trials and policy advocacy. As trends rise, universities will lead therapeutic access.

For careers, visit university jobs, higher ed jobs, and higher ed career advice.

Photo by Nik Schmidt on Unsplash